Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation (Q90066593)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

title

Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

author name string

Tuong N Vu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

Xuesong Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

Hussein D Foda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

Gerald C Smaldone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

publication date

11 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

page(s)

206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

Effect of gamma-interferon on collagen synthesis by normal and fibrotic human lung fibroblasts

11 April 2020

cites work

1 reference

12 December 2020

Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung

1 reference

12 December 2020

Effects of interferon-gamma on expression of cell surface receptors for collagen and deposition of newly synthesized collagen by cultured human lung fibroblasts

1 reference

12 December 2020

Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation

1 reference

12 December 2020

Expression of a 2.8-kb PDGF-B/c-sis Transcript and Synthesis of PDGF-Like Protein by Human Lung Fibroblasts

1 reference

12 December 2020

Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study

1 reference

12 December 2020

Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression

1 reference

12 December 2020

Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis

1 reference

12 December 2020

Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds

1 reference

12 December 2020

Keloid excision and recurrence prophylaxis via interdermal interferon-gamma injections

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification

1 reference

12 December 2020

Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

1 reference

12 December 2020

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis

1 reference

12 December 2020

TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?

1 reference

12 December 2020

Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators

1 reference

12 December 2020

Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis.

1 reference

12 December 2020

Demonstration of downregulation of alpha-smooth muscle actin in interferon-gamma-treated myofibroblast by a novel cell-capture enzyme immunoassay

1 reference

12 December 2020

Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality

1 reference

12 December 2020

The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3)

1 reference

12 December 2020

Pirfenidone inhibits early myointimal proliferation but has no effect on late lesion size in rats

1 reference

12 December 2020

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans

1 reference

12 December 2020

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

12 December 2020

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

1 reference

12 December 2020

Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis?

1 reference

12 December 2020

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

1 reference

12 December 2020

Syndecan-2 regulates transforming growth factor-beta signaling

1 reference

12 December 2020

Regulation of PDGF and its receptors in fibrotic diseases

1 reference

12 December 2020

Effect of IFN-gamma and dexamethasone on TGF-beta1-induced human fetal lung fibroblast-myofibroblast differentiation

1 reference

12 December 2020

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

1 reference

12 December 2020

Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice

1 reference

12 December 2020

Cyclic mechanical strain-induced proliferation and migration of human airway smooth muscle cells: role of EMMPRIN and MMPs

1 reference

12 December 2020

Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts

1 reference

12 December 2020

Epithelial origin of myofibroblasts during fibrosis in the lung

1 reference

12 December 2020

Matrix metalloproteases in aberrant fibrotic tissue remodeling

1 reference

12 December 2020

Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein

1 reference

12 December 2020

Opposite effects of TGF-beta1 and IFN-gamma on transdifferentiation of myofibroblast in human gingival cell cultures

1 reference

12 December 2020

Molecular targets in pulmonary fibrosis: the myofibroblast in focus.

1 reference

12 December 2020

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

1 reference

12 December 2020

Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production.

1 reference

12 December 2020

Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.

1 reference

12 December 2020

Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance

1 reference

12 December 2020

Increased Neovascularization in Mice Lacking Tissue Inhibitor of Metalloproteinases-3

1 reference

12 December 2020

Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011

1 reference

12 December 2020

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

1 reference

12 December 2020

Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair.

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production

1 reference

12 December 2020

Matrix metalloproteinase 3 is a mediator of pulmonary fibrosis

1 reference

12 December 2020

Series "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in COPD.

1 reference

12 December 2020

STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF.

1 reference

12 December 2020

Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells

1 reference

12 December 2020

Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis.

1 reference

12 December 2020

Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation

1 reference

12 December 2020

IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice

1 reference

12 December 2020

Matrix metalloproteinase (MMP)-1 induces lung alveolar epithelial cell migration and proliferation, protects from apoptosis, and represses mitochondrial oxygen consumption

1 reference

12 December 2020

Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.

1 reference

12 December 2020

Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts.

1 reference

12 December 2020

Diverse functions of matrix metalloproteinases during fibrosis

1 reference

12 December 2020

Update on therapeutic management of idiopathic pulmonary fibrosis

1 reference

12 December 2020

Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis

1 reference

12 December 2020

Inhaled Interferon and Diffusion Capacity in Idiopathic Pulmonary Fibrosis (IPF).

1 reference

12 December 2020

Pulmonary Fibrosis Treated with Inhaled Interferon-gamma (IFN-γ).

1 reference

12 December 2020

Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents

1 reference

12 December 2020

Cellular senescence-like features of lung fibroblasts derived from idiopathic pulmonary fibrosis patients.

1 reference

12 December 2020

The myofibroblast, a key cell in normal and pathological tissue repair.

1 reference

12 December 2020

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis.

1 reference

12 December 2020

Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts

1 reference

12 December 2020

Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis

1 reference

12 December 2020

Pirfenidone inhibits the proliferation of fibroblasts from patients with active Crohn's disease.

1 reference

12 December 2020

Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice.

1 reference

12 December 2020

Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors

1 reference

12 December 2020

A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly

1 reference

12 December 2020

Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy

1 reference

12 December 2020

Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.

1 reference

12 December 2020

Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis

1 reference

12 December 2020

10.1186/S12931-019-1171-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31511015 AND SRC:MED&resulttype=core&format=json

11 April 2020

PubMed publication ID

31511015

1 reference